Cytokine mediated expansion of human umbilical cord blood CD34+ cells: comparison of the use of partially purified and pure CD34+ target cells

被引:13
作者
Case, J [1 ]
Rice, A [1 ]
Vowels, M [1 ]
机构
[1] SYDNEY CHILDRENS HOSP, CHILDRENS LEUKAEMIA & CANC RES CTR, BONE MARROW TRANSPLANT LAB, RANDWICK, NSW 2031, AUSTRALIA
关键词
cord blood CD34 progenitor cells; cytokine mediated expansion;
D O I
10.1007/s00282-997-0193-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine the optimal cell population for cytokine mediated expansion, we compared the use of Magnetic Cell Sorting (MACS) system enriched CD34+ human umbilical cord blood (HUCB) cells with that of MACS enriched, flow purified CD34+ HUCB cells. Both MACS enriched CD34+ cells and MACS enriched, flow purified CD34+ cells (mean starting purity of CD34+ SC 51.27 +/- 7.6% and 96.36 +/- 1.34% respectively n = 6) were incubated for seven days with Interleukin-1 (IL-1)+IL-3+Stem Cell Factor (SCF) and showed a fold increase in the number of nucleated cells (10.02 +/- 2.6 and 18.23 +/- 4.73 respectively) and a reduction in the percentage of CD34+ cells (5.55 +/- 1.23% and 12.21 +/- 3.29% respectively). An increase in the absolute numbers of CD34+ cells (4.8 x 10(4) +/- 2.3 x 10(4)) was observed with MACS enriched CD34+ cells as compared to no change (1.3 x 10(5) +/- 8.8 x 10(4)) with MACS enriched, flow purified CD34+ cells. An increase in IL-3+GM-CSF+SCF responsive colony forming unit (CFU) (1.7 x 10(4) +/- 9.4 x 10(3) and 1.6 x 10(5) +/- 7.7 x 10(4) respectively) was also observed as compared with input values (1.5 x 10(4) +/- 1 x 10(4) and 2.3 x 10(4) +/- 8.9 x 10(3) respectively). We conclude that MACS enriched, flow sorted CD34+ HUCB cells have greater cytokine mediated expansion potential as measured by progenitor expansion, than MACS enriched CD34+ HUCB cells.
引用
收藏
页码:193 / 197
页数:5
相关论文
共 18 条
[1]  
ABBOUD MR, 1994, EXP HEMATOL, V22, P388
[2]   ANTIGEN CD34+ MARROW-CELLS ENGRAFT LETHALLY IRRADIATED BABOONS [J].
BERENSON, RJ ;
ANDREWS, RG ;
BENSINGER, WI ;
KALAMASZ, D ;
KNITTER, G ;
BUCKNER, CD ;
BERNSTEIN, ID .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (03) :951-955
[3]  
BERENSON RJ, 1991, BLOOD, V77, P1717
[4]  
BERTOLINI F, 1994, BONE MARROW TRANSPL, V14, P347
[5]   RETRACTED: RECONSTITUTION OF HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY BY AUTOLOGOUS PROGENITOR CELLS GENERATED EX-VIVO (RETRACTED ARTICLE. SEE VOL 345, PG 64, 2001) [J].
BRUGGER, W ;
HEIMFELD, S ;
BERENSON, RJ ;
MERTELSANN, R ;
KANZ, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :283-287
[6]  
CHAMPLIN R, 1996, P 4 INT S BLOOD CELL
[7]   MODULATION OF HUMAN CORD-BLOOD PROGENITOR-CELL GROWTH BY RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3), IL-6, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AND STEM-CELL FACTOR (SCF) IN SERUM-SUPPLEMENTED AND SERUM-FREE MEDIUM [J].
DEBRUYN, C ;
DELFORGE, A ;
BRON, D ;
LEY, P ;
DEHEMPTINNE, D ;
STRYCKMANS, P .
STEM CELLS, 1994, 12 (06) :616-625
[8]  
MIGLIACCIO AR, 1993, STEM CELLS, V11, P56
[9]  
MOORE MAS, 1995, SEMIN HEMATOL, V32, P183
[10]  
MOORE MAS, 1994, BLOOD CELLS, V20, P468